Finance

Lists
Q3 2026 earnings • released • EPS beat +14 014,11% • Revenue met 0,00%
See results
PHM:BME
Pharma Mar SA
€67,50
-2,53%
(-1,75) 1D
30 Okt., 17:36:00 GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for PHM...
Open
€68,90
High
€69,35
Low
€66,00
Mkt. cap
1,24 mjd
Avg. vol.
26,90 k
Volume
71,66 k
Dividend
1,48%
Quarterly dividend
€0,25
Ex-dividend date
07 Jun. 2023
P/E ratio
20,54
52-wk high
€105,20
52-wk low
€64,00
EPS
€3,29
Shares outstanding
18,00 m
No. of employees
505
Open
€68,90
High
€69,35
Low
€66,00
Mkt. cap
1,24 mjd
Avg. vol.
26,90 k
Volume
71,66 k
Dividend
1,48%
Quarterly dividend
€0,25
Ex-dividend date
07 Jun. 2023
P/E ratio
20,54
52-wk high
€105,20
52-wk low
€64,00
EPS
€3,29
Shares outstanding
18,00 m
No. of employees
505
News stories
From web sources and news partners
About Pharma Mar SA
CEO-
Employees505
Founded1986
Headquarters-
Sector-
Websitepharmamar.com
Last report
29 Okt. 2026
Fiscal period
Q3 2026
€0,47 / €0,00
+14 014,11%beat
Revenue / Est. (EUR)
0,00 / 50,68 m
0,00%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
35,66 m
90,48 m
42,90 m
49,60 m
Cost of goods sold
2,30 m
3,77 m
3,66 m
4,73 m
Cost of revenue
2,30 m
3,77 m
3,66 m
4,73 m
Research and development expenses
22,13 m
25,59 m
20,88 m
26,38 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,63 m
17,31 m
15,31 m
17,12 m
Operating expense
37,32 m
43,09 m
38,62 m
46,28 m
Total operating expenses
39,62 m
46,87 m
42,28 m
51,01 m
Operating income
-3,96 m
43,61 m
622,00 k
-1,40 m
Other non operating income
-
-
-
-
EBT including unusual items
-4,08 m
44,28 m
1,60 m
-993,00 k
EBT excluding unusual items
-4,08 m
44,28 m
1,60 m
-993,00 k
Income tax expense
24,00 k
-15,39 m
65,00 k
-21,00 k
Effective tax rate
-0,59%
-34,75%
4,07%
2,11%
Other operating expenses
8,56 m
195,00 k
2,43 m
2,77 m
Net income
-4,10 m
59,66 m
1,53 m
-972,00 k
Net profit margin
-11,50%
65,95%
3,57%
-1,96%
Earnings per share
-
-
-
-
Interest and investment income
-
3,44 m
976,00 k
412,00 k
Interest expense
-117,00 k
-724,00 k
-
-
Net interest expenses
-117,00 k
2,72 m
976,00 k
412,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,95 m
45,64 m
2,71 m
700,00 k
Gain or loss from assets sale
-10,00 k
-754,00 k
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme